Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib and Lipo-Dox in HER2+ Metastatic Breast Cancer
NCT01658358Phase 2Terminated
- Sponsor
- China Medical University Hospital
- Start
- Jul 2012
- Primary completion
- Sep 2014
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by China Medical University Hospital. Started Jul 2012; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01658358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01658358.